Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

HistoSonics Secures $250M in Series D Funding, Accelerating Commercialization of Innovative Cancer Treatment Technology

HistoSonics Secures $250M in Series D Funding, Accelerating Commercialization of Innovative Cancer Treatment Technology

HistoSonics, a pioneering developer of non-invasive cancer treatments, has successfully raised $250 million in an oversubscribed Series D financing round. This substantial investment comes just two months after a syndicate of investors acquired a majority stake in the company, valuing it at $2.5 billion. The latest funding injection is set to propel the commercial expansion of HistoSonics' groundbreaking Edison System, which utilizes advanced sonic beam technology to target and destroy tumors.

NoahAI News10/21/2025
Merck Announces $3 Billion Investment in Virginia, Part of $70 Billion US Manufacturing Push

Merck Announces $3 Billion Investment in Virginia, Part of $70 Billion US Manufacturing Push

Merck & Co. has unveiled plans for a substantial $3 billion investment in Elkton, Virginia, marking a significant expansion of its manufacturing capabilities in the United States. This announcement is part of a broader $70 billion commitment to bolster US-based manufacturing, research and development, and capital projects, positioning Merck at the forefront of pharmaceutical industry growth in the country.

NoahAI News10/21/2025
FarmboxRx Founder Joins HLM Investment Partners, Brings Unique Perspective to Healthcare Startups

FarmboxRx Founder Joins HLM Investment Partners, Brings Unique Perspective to Healthcare Startups

Ashley Tyrner-Dolce, the founder of FarmboxRx, has joined HLM Investment Partners as an operating partner, bringing her entrepreneurial experience to help guide new healthcare startups. This move comes after the successful acquisition of FarmboxRx by Pyx Health in June for nearly $50 million, marking a significant milestone in Tyrner-Dolce's career and the food-as-engagement healthcare sector.

NoahAI News10/21/2025
European Biotechs Join Forces to Tackle Neurodegenerative Diseases

European Biotechs Join Forces to Tackle Neurodegenerative Diseases

In a significant move for the pharmaceutical industry, two European biotech companies have announced a collaboration aimed at revolutionizing the treatment of neurodegenerative diseases. Swiss-based Indivi and Belgian firm Clouds of Care have partnered to leverage precision medicine tools in the early phases of drug development for conditions such as Alzheimer's and Parkinson's disease.

NoahAI News10/21/2025
FDA Accepts Replimune's Melanoma Drug Resubmission, Setting April 2026 Decision Date

FDA Accepts Replimune's Melanoma Drug Resubmission, Setting April 2026 Decision Date

The U.S. Food and Drug Administration (FDA) has accepted Replimune's resubmission of its biologics license application for RP1, a novel melanoma treatment. This development comes after the agency's initial rejection of the drug earlier this year, sparking both controversy and renewed hope for patients with advanced melanoma.

NoahAI News10/21/2025
Innovative Manufacturing Approaches Accelerate Clinical Timelines in Pharmaceutical Industry

Innovative Manufacturing Approaches Accelerate Clinical Timelines in Pharmaceutical Industry

In a rapidly evolving pharmaceutical landscape, drug developers are facing increasing pressure to accelerate timelines and optimize resource allocation. A recent breakthrough in manufacturing strategy promises to address these challenges, particularly in early-stage clinical trials.

NoahAI News10/21/2025
WeightWatchers Partners with Amazon Pharmacy to Enhance Weight Loss Medication Access

WeightWatchers Partners with Amazon Pharmacy to Enhance Weight Loss Medication Access

WeightWatchers, a leader in the weight management industry, has announced a strategic partnership with Amazon Pharmacy to improve access to weight loss medications for its members. The collaboration, unveiled at the HLTH conference in Las Vegas, aims to streamline the process of obtaining weight management drugs through home delivery and automated savings.

NoahAI News10/21/2025
Hartford HealthCare's $86.1M Bid for Prospect Hospitals Accepted, Awaits Court Approval

Hartford HealthCare's $86.1M Bid for Prospect Hospitals Accepted, Awaits Court Approval

Hartford HealthCare's $86.1 million bid to acquire two Connecticut hospitals from bankrupt Prospect Medical Holdings has been accepted, marking a significant development in the ongoing restructuring of the state's healthcare landscape. The deal, which includes Manchester Memorial and Rockville General hospitals, now awaits final approval from a bankruptcy judge.

NoahAI News10/21/2025
Theravance Biopharma Launches Physician Education Campaign for Rare Neurological Disorder

Theravance Biopharma Launches Physician Education Campaign for Rare Neurological Disorder

Theravance Biopharma has initiated a new physician education campaign focused on neurogenic orthostatic hypotension (nOH) associated with multiple system atrophy (MSA), a rare and progressive brain disorder. The campaign, titled "Power in the Periphery," comes ahead of anticipated phase 3 clinical trial results for the company's investigational drug, ampreloxetine.

NoahAI News10/21/2025
US Private Equity Market Shows Signs of Recovery, Positioning for Strong Year-End

US Private Equity Market Shows Signs of Recovery, Positioning for Strong Year-End

The U.S. private equity (PE) market is experiencing a resurgence, with robust deal activity and favorable interest rates driving optimism across sectors. Despite ongoing challenges in exits and fundraising, the industry is poised to end the year on a high note, according to a recent PitchBook report.

NoahAI News10/21/2025
Counteracting Complacency in Multiple Myeloma: The Road to a Cure Remains Long

Counteracting Complacency in Multiple Myeloma: The Road to a Cure Remains Long

In recent years, the multiple myeloma treatment landscape has undergone a remarkable transformation, with survival rates nearly doubling and over 15 FDA-approved therapies now available. However, industry experts warn against premature celebrations, emphasizing that significant challenges remain in the quest for a true cure.

NoahAI News10/21/2025
FDA Leadership Exodus Reshapes Pharmaceutical Industry Landscape

FDA Leadership Exodus Reshapes Pharmaceutical Industry Landscape

In a seismic shift for the pharmaceutical industry, a mass exodus of senior leadership from the U.S. Food and Drug Administration (FDA) has led to a significant reshuffling of key personnel across major drug companies and biotech firms. This transition, occurring amidst a tumultuous political climate, has raised questions about the revolving door between regulators and industry while potentially reshaping the future of drug development and approval processes.

NoahAI News10/21/2025
«1...171819...67»